KALA BIO, Inc.
KALA
Classement en actions
#30847
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Prix de l'action
$0.75
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$14.50M
Changement (1 jour)
2.78%
Changement (1 an)
-98.42%
Pays
US
Échange KALA BIO, Inc. (KALA)
Catégorie
Healthcare
Ratio P/S pour KALA BIO, Inc. (KALA)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de KALA BIO, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour KALA BIO, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| Pas assez de données pour les dates fournies. | ||
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
